纽福斯（上海）生物科技有限公司
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Neurophth Closes RMB 400 Million Series B Financing 2021-02-09 21:44
Neurophth Therapeutics Further Expands Ocular Gene Therapy Expertise with Appointment of Qiutang Li, Ph.D., as Chief Scientific Officer 2021-01-27 21:00
Neurophth and AAVnerGene Enter Strategic AAV Capsids Partnership for Next-Generation Ophthalmic Gene Therapy 2021-01-19 14:05
Neurophth Therapeutics' Treatment of Leber's Hereditary Optic Neuropathy Gene Therapy NR082 was Granted Orphan Drug Designation by U.S. FDA 2020-09-25 10:37
Neurophth Therapeutics Announces Presentations at ASGCT and ARVO Annual Meetings 2020-05-11 20:00
1 2